Amneal Pharmaceuticals Inc. share price logo

Amneal Pharmaceuticals Inc. Share Price

NYSE: AMRX

Mid Cap

$9.80

-0.20

(-2.00%)

as on

Amneal Pharmaceuticals Inc. Stock Performance

as on September 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $9.76
    $10.04
    downward going graph

    0.41%

    Downside

    2.45%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $6.69
    $10.34
    downward going graph

    31.79%

    Downside

    5.51%

    Upside

    downward going graph

Amneal Pharmaceuticals Inc. share price movements today

Previous Close
$10.00
Open
$10.04
Volume
1.2M
Day's Low - High
$9.76 - $10.04
52 Week Low - High
$6.69 - $10.34

Amneal Pharmaceuticals Inc. Historical Returns

1 Month Return
+ 5.82 %
3 Month Return
+ 29.03 %
1 Year Return
+ 16.01 %
3 Year Return
+ 325.53 %
5 Year Return
+ 147.52 %

Amneal Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Amneal Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.1B

EPS (TTM)

0.7627

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

2.61%

PE Ratio (TTM)

1000

Industry PE ratio

10.127857142857144

P/B Ratio

1000

PEG Ratio

0

EBITDA

625.2M

Revenue (TTM)

2.9B

Profit Margin

0.12%

Return On Equity TTM

-881.26%

Amneal Pharmaceuticals Inc. Stock Valuation

Track how Amneal Pharmaceuticals Inc. P/E has moved over time to understand its valuation trends.

Amneal Pharmaceuticals Inc. in the last 5 years

  • Overview

  • Trends

Lowest (2.93x)

March 31, 2023

Industry (10.13x)

September 15, 2025

Today (1000.00x)

September 15, 2025

Highest (17.39x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 1000.00x

Amneal Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Amneal Pharmaceuticals Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$3.1B147.52%10000.12%
BUY$18.3BNA15.840.36%
BUY$44.1BNA21.813.81%
BUY$14.1B36.02%41.9713.88%
BUY$65.7B-8.68%25.5127.83%

Stock Returns calculator for Amneal Pharmaceuticals Inc. Stock including INR - Dollar returns

The Amneal Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Amneal Pharmaceuticals Inc. investment value today

Current value as on today

₹1,18,674

Returns

₹18,674

(+18.67%)

Returns from Amneal Pharmaceuticals Inc. Stock

₹13,689 (+13.69%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Amneal Pharmaceuticals Inc. Stock

Based on 11 analysts

BUY

81.82%

Buy

9.09%

Hold

9.09%

Sell

Based on 11 analysts, 81.82% of analysts recommend a 'BUY' rating for Amneal Pharmaceuticals Inc.. Average target price of $12

Amneal Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on Amneal Pharmaceuticals Inc..

What analysts predicted

18.33%UPSIDE

Target Price

$12

Current Price

$9.8

Analyzed by

11 Analysts

Target

$12.00

Amneal Pharmaceuticals Inc. target price $12, a slight upside of 18.33% compared to current price of $9.8. According to 11 analysts rating.

Amneal Pharmaceuticals Inc. Stock's Interest Amongst Investors

Search interest for Amneal Pharmaceuticals Inc. Stock has increased by 58% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:58% versus previous 30 day period

Amneal Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
557
599
620
616
659
701
702
730
695
724
Gross Profit
178
220
232
236
238
249
269
262
255
286
Operating Income
34
80
75
14
-10
95
88
75
100
111
EBITDA
106
137
131
138
140
151
139
112
154
176
Interest Expense
49
50
50
59
65
65
65
61
56
65
Depreciation
58
57
57
56
55
55
58
66
60
60
Income Before Tax
-9
29
22
-83
-75
20
15
-15
37
51
Income Tax Expense
0
0
-2
9
6
3
3
5
12
16
Net Income
-10
11
9
-98
-91
5
0
-31
12
22
Net Profit Margin
-1.81%
1.99%
1.56%
-15.99%
-13.90%
0.85%
-0.02%
-4.25%
1.75%
3.09%

Amneal Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
866
1,018
1,033
1,662
1,626
1,992
2,093
2,212
2,393
2,793
Gross Profit
499
597
526
716
352
628
783
791
820
1,020
Operating Income
227
284
245
-19
-137
91
152
-94
204
249
EBITDA
252
306
271
-19
155
345
401
150
399
439
Interest Expense
-
55
71
143
168
145
136
158
210
258
Depreciation
-
-
45
137
207
235
233
240
229
236
Income Before Tax
175
214
171
-202
-220
-35
31
-248
-40
-55
Income Tax Expense
4
5
1
-1
383
-104
11
6
8
18
Net Income
169
207
167
-169
-603
91
10
-129
-83
-116
Net Profit Margin
19.56%
20.37%
16.22%
-10.21%
-37.11%
4.57%
0.51%
-5.88%
-3.51%
-4.18%

Amneal Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
29
25
-93
-81
16
11
-20
24
35
Operating Cash Flow
-11
81
135
-4
39
141
118
7
83
Investing Cash Flow
-12
-13
-31
-19
-6
-20
-16
-17
-26
Financing Cash Flow
-12
-86
-100
-23
-35
-92
-61
-39
-41
Change in Cash
-36
-18
3
-47
-1
28
40
-50
15

Amneal Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
209
169
-201
-603
68
10
-254
-48
-73
Operating Cash Flow
115
234
250
1
379
241
65
345
295
Investing Cash Flow
-124
-98
-396
-19
-317
-194
-174
-69
-62
Financing Cash Flow
-19
-95
287
-45
131
-138
-106
-212
-211
Change in Cash
-27
40
140
-65
194
-90
-221
63
19

Global Institutional Holdings in Amneal Pharmaceuticals Inc.

Funds
Holdings
Vanguard Group Inc
5.02%
BlackRock Inc
4.01%
TPG GP A, LLC
3.93%
Rubric Capital Management LP
3.42%
Citadel Advisors Llc
2.39%

Insights on Amneal Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 695.42M → 724.50M (in $), with an average increase of 4.0% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -31.08M → 22.41M (in $), with an average increase of 200.2% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 years, AMRX stock has moved up by 318.4%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, AMRX has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation has given 16.9% return, outperforming this stock by 5.4%

About Amneal Pharmaceuticals Inc.

an american pharmaceutical company, amneal develops and produces affordable medicines. the company was built upon a family tradition of quality and integrity. everything amneal does, across the full spectrum of its business, is in service to these guiding principles. amneal is committed to constantly elevating and refining the value it delivers to its customers and patients around the globe.
OrganisationAmneal Pharmaceuticals Inc.
Headquarters400 Crossing Boulevard, Bridgewater, NJ, United States, 08807
IndustryHealth Technology
CEOMr. Chirag K. Patel
E-voting on sharesClick here to vote

Key Management of Amneal Pharmaceuticals Inc.

Name

Title

Mr. Anastasios G. Konidaris

Executive VP & CFO

Mr. Jason B. Daly Esq.

Executive VP, Chief Legal Officer & Corporate Secretary

Mr. Andrew S. Boyer

Executive VP and Chief Commercial Officer of Generics & Biosciences

Mr. Anthony DiMeo

Head of Investor Relations

Mr. Chirag K. Patel

Co-Founder, Co-CEO, President & Director

Mr. Chintu Patel R.Ph.

Co-Founder, Co-CEO & Director

Mr. Pranav Mehta

Senior VP of Strategic Sourcing & Supply Management

Dr. Sanjay Kumar Jain Ph.D.

Chief Quality Officer

Ms. Nikita Shah

Executive VP & Chief Human Resources Officer

Mr. Gregory Sgammato

Senior Vice President of Corporate Development

FAQs

What is Amneal Pharmaceuticals Inc. share price today?

Amneal Pharmaceuticals Inc. share price today is $9.8 as on at the close of the market. Amneal Pharmaceuticals Inc. share today touched a day high of $10.04 and a low of $9.76.

What is the 52 week high and 52 week low for Amneal Pharmaceuticals Inc. share?

Amneal Pharmaceuticals Inc. share touched a 52 week high of $10.34 on and a 52 week low of $6.69 on . Amneal Pharmaceuticals Inc. stock price today i.e. is closed at $9.8,which is 5.22% down from its 52 week high and 46.60% up from its 52 week low.

What is Amneal Pharmaceuticals Inc.'s market capitalisation today?

Amneal Pharmaceuticals Inc. market capitalisation is $0.00T as on .

How to invest in Amneal Pharmaceuticals Inc. Stock (AMRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Amneal Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Amneal Pharmaceuticals Inc. Shares that will get you 0.1531 shares as per Amneal Pharmaceuticals Inc. share price of $9.8 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Amneal Pharmaceuticals Inc. Stock (AMRX) from India?

Indian investors can start investing in Amneal Pharmaceuticals Inc. (AMRX) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Amneal Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Amneal Pharmaceuticals Inc. share’s latest price of $9.8 as on September 16, 2025 at 1:29 am IST, you will get 1.0204 shares of Amneal Pharmaceuticals Inc.. Learn more about fractional shares .

What are the returns that Amneal Pharmaceuticals Inc. has given to Indian investors in the last 5 years?

Amneal Pharmaceuticals Inc. stock has given 147.52% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?